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Adult stems cells, possessing the ability to grow, migrate, proliferate, and transdifferentiate into various 
specific phenotypes including, neuronal or glial cell types, constitute a great asset for biomedical 
applications involving peripheral nerve regeneration. Adult stem cell plasticity, in particular their ability to 
undergo transdifferentiation, is sensitive to various cellto- cell interactions and external stimuli involving 
the interactions with physical, mechanical and chemical cues within their microenvironment. Various 
studies have employed different techniques for transdifferentiating adult stem cells from distinct sources 
into specific lineages (e.g., glial cells and neurons). These techniques include using chemical and/or 
electrical induction as well as cell-to-cell synergetic effects via co-culture along with the use of various 3D 
conduit/scaffold designs. Such scaffolds consist of unique natural and/or synthetic materials that 
possess controllable physical/mechanical properties that can mimic the natural extracellular matrix 
environment of the cells. However, the current limitations regarding the final fate of implanted 
transdifferentiated stem cell populations, non-scalable transdifferentiation protocols, and design of a 
conduit/scaffold that mimics the complex extracellular matrix microenvironment have required 
development of new strategies for the effective transdifferentiation of stem cells and their implantation. 
In this progress report, we present a comprehensive review of recent advances in the transdifferentiation 
of adult stem cells into particularly Schwann cells or neurons via different approaches (chemical and/or 
electrical stimuli or co-culture with different cells) along with multifunctional conduit/scaffolds materials 
and designs. We also included potential cellular mechanisms and signaling pathways associated with 
stem cell differentiation. We conclude the discussion with some of the challenges that still need to be 
overcome in the field and provide an outlook toward future research directions. 
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Abstract  
Adult stems cells, possessing the ability to grow, migrate, proliferate, and transdifferentiate 
into various specific phenotypes including, neuronal or glial cell types, constitute a great 
asset for biomedical applications involving peripheral nerve regeneration. Adult stem cell 
plasticity, in particular their ability to undergo transdifferentiation, is sensitive to various cell-
to-cell interactions and external stimuli involving the interactions with physical, mechanical 
and chemical cues within their microenvironment. Various studies have employed different 
techniques for transdifferentiating adult stem cells from distinct sources into specific lineages 
(e.g., glial cells and neurons).  These techniques include using chemical and/or electrical 
induction as well as cell-to-cell synergetic effects via co-culture along with the use of various 
3D conduit/scaffold designs.  Such scaffolds consist of unique natural and/or synthetic 
materials that possess controllable physical/mechanical properties that can mimic the natural 
extracellular matrix environment of the cells. However, the current limitations regarding the 
final fate of implanted transdifferentiated stem cell populations, non-scalable 
transdifferentiation protocols, and design of a conduit/scaffold that mimics the complex 
extracellular matrix microenvironment have required development of new strategies for the 
effective transdifferentiation of stem cells and their implantation. In this progress report, we 
present a comprehensive review of recent advances in the transdifferentiation of adult stem 
cells into particularly Schwann cells or neurons via different approaches (chemical and/or 
electrical stimuli or co-culture with different cells) along with multifunctional conduit/scaffolds 
materials and designs. We also included potential cellular mechanisms and signaling 
pathways associated with stem cell differentiation.  We conclude the discussion with some of 
the challenges that still need to be overcome in the field and provide an outlook toward 
future research directions.    
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1. Introduction 
Peripheral nerve (PN) injuries affect 2.8% of trauma patients, frequently leading to life-long 
disability, reduced quality of life, and heavy economic and social burdens. [1-3] The incidence 
of PN injuries is high world-wide and over 200,000 PN repair procedures are performed 
annually in the US alone, resulting in ~ $1.3 – 1.9 billion spent. [1-3] Current treatment 
strategies have shown limited success and often result in incomplete recovery with poor 
functional outcomes, especially for large PN injuries. Although the peripheral nervous 
system (PNS) has an intrinsic capacity to regenerate and regrow axons to a certain extent 
through the growth permissive Schwann cells (SCs), spontaneous nerve regeneration in 
PNS has resulted in poor functional outcomes.[3-5] In particular, the recovery from large PN 
gaps is difficult to achieve without any therapeutic intervention or cell-based therapy.[3] 
The current gold standard for severe peripheral nerve transection injuries are 
autologous nerve grafts. However, this treatment strategy has significant disadvantages 
such as biological complexity, donor site morbidity, limited length of graft tissue availability, 
and the requirement of multiple surgeries.[1-3] As an alternative strategy, the application of 
cell-based nerve regeneration therapies holds considerable promise for treatment of large 
PN injuries. Schwann cells, which form the myelin sheath around peripheral axons, produce 
numerous factors that serve to promote regeneration including extracellular matrix (ECM) 
molecules and neurotrophic factors along with Schwann cell integrins. Among these 
neurotrophic/growth factors, nerve growth factor (NGF), brain-derived neurotrophic factor 
(BDNF), and glial cell line-derived neurotrophic factor (GDNF) enhance guidance and 
support for regenerating axons.[6-11]  Hence, biodegradable nerve regeneration or guidance 
conduits (NGCs) bearing SCs have shown perhaps the most promising strategy for PN 
nerve repair. However, this strategy has not transitioned to clinical use because of limited 
availability, donor site morbidity, and slow in vitro growth of SCs.[12-14] As a new approach, in 
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4 
vitro transdifferentiated somatic stem cells possessing SC-like or neural phenotypes have 
recently been explored for PN regeneration.[15-27] Adult stem cells, isolated and derived from 
bone-marrow, adipose tissue or other connective tissue sources, have considerable 
translational potential for cell-based nerve regeneration therapies using autologous 
transplantation due to the lack of ethical concerns, accessibility, plasticity, multipotent 
nature, and transdifferentiation ability into functional cell types. These stem cells also have 
the ability to repair tissue through paracrine activity by cytokine production; to release 
neurotrophic factors including, NGF, BDNF and GDNF.[15, 20, 21, 28, 29] However, this strategy 
has not widely transitioned into clinical use due to three main challenges: lack of reliability in 
controlling the final fate of the implanted cell population, especially over the regeneration 
period; non-scalable transdifferentiation protocols; and challenges in designing a 
multifunctional conduit that mimics the complex ECM microenvironment.[30, 31] Thus, there is 
a critical need to overcome these challenges to make stem cell-based strategies a viable 
solution for PN injury repair. This review article primarily focuses on recent advances 
regarding adult stem cell transdifferentiation strategies, along with various conduit designs 
and materials for stem cell-based therapies targeting PN injuries. Previous review 
manuscripts have focused primarily on biomaterials and conduit-based strategies [32] for 
peripheral nerve regeneration while others have included detailed information on stem cell 
types and sources and various clinical studies.[33, 34].  Here we focus on collating the latest 
research on adult stem cell differentiation strategies and mechanisms including those that 
involve chemical, electrical or mechanical cues as well as unique combinations of multiple 
cues.  Moreover, this progress report reviews the current state-of-the art with regards to 
conduit/scaffold materials that facilitate PN regeneration via said cues.   
 
2. Stem Cell Function, Differentiation and Fate Commitment 
Somatic stem cells, obtained from various connective tissue sources, possess a number of 
qualities well-suited for cell-based therapies including ease of isolation, rapid in vitro growth, 
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efficient host tissue integration, and extended in vivo survival. These stem cells are also 
considered a promising cellular source to provide replacement of lost neurons and glial 
support cells for nerve regeneration.[35, 36] It is also possible to modify stem cells via stable 
transfection to enable expression of exogenous genes for an efficient therapy. Furthermore, 
in vitro and in vivo studies have demonstrated their transdifferentiation into SC-like 
phenotypes and/or neurons and integration into Bands of Büngner, facilitating axonal 
guidance and re-myelination through enhanced secretion of growth factors and ECM 
proteins upon in vivo transplantation.[37-39] The cell-to-cell contacts and paracrine signaling 
serves to modulate the active molecule-secreting capabilities of transdifferentiated stem 
cells, and also synergistically induces the secretory activity of endogenous SCs and 
macrophage accumulation near the site of injury.[39, 40] 
Numerous growth factors (i.e. NGF, BDNF, GDNF, and neurotrophin-3 (NT-3)), along 
with ECM proteins (i.e. collagen I & IV, fibronectin and laminin) and neurite guidance 
proteins (i.e. netrin and ninjurin-2), produced by endogenous SCs and transplanted stem 
cells have a profound effect on nerve regeneration [39, 41-47]. Neurotrophic factors, including 
neurotrophin family members and CNTF, all act on the MAPK/ERK, PI-3K/Akt, and 
JAK/STAT3 pathways. These factors activate protein kinase A(PKA), Ras/phosphotidyl 
inositol 3’-phosphate-kinase (PI-3K)/Akt, and Ras/Raf/mitogen-activated protein kinase 
(MAPK) and MAPK/extracellular signal regulated kinase (ERK) signal transduction 
pathways, leading to their biological actions upon binding to their specific high-affinity 
cognate tyrosine kinase (Trk) receptor.[48]  
In addition, it was further demonstrated that the macrophage accumulation in the 
injury area and immunomodulatory effects of stem cells, which can potentially reduce the 
adverse effect of inflammation and fibrosis following nerve repair, can also be maintained via 
the secretion of factors such as granulocyte and macrophage colony stimulating factor (G-
CSF, M-CSF), interleukin-6, 7, 8, and 11 (IL-6, IL-7, IL-8, IL-11) and tumor necrosis factor-α 
(TNF-α).[45, 47] However, it was noted that some of the ECM proteins have inhibitory effects 
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on axonal regeneration which was shown to be circumvented through the degradation of 
these proteins via the secretion of matrix metalloproteinase-2 (MMP-2) to support 
regeneration.[49, 50] Each of these ECM proteins or growth factors secreted by the stem cells 
trigger different cellular pathways and therefore different mechanisms to mediate 
regeneration.[51] The type of stem cell, its source and differentiation status, along with the 
method of cell delivery and properties of scaffold material and design, determines the levels 
of ECM protein and growth factor secretion as well as the benefit for each mechanism.[37, 38, 
47, 52] 
Somatic stem cells can be directly transplanted without applying in vitro 
transdifferentiation procedures. In some studies, the positive effects of directly transplanting 
undifferentiated stem cells, either alone or in co-culture with Schwann cells, on neural 
regeneration have been reported, highlighting the disadvantages of in vitro 
transdifferentiation procedures such as extra time, effort and cost spent, with unnecessary 
delays and limiting clinical applicability[39, 43, 44, 53-64]. Moreover, this strategy was also used to 
provide in-situ and in vivo differentiation of transplanted stem cells in response to local 
stimuli around the transplantation site.[56, 63, 65-67] However, there are concerns regarding the 
potential of undifferentiated cells to differentiate into unwanted, non-neural lineages in the 
complex in vivo environment bearing various growth factors, ECM proteins and other 
dominant cells in the area. Hence, some studies reported undesired differentiation of 
undifferentiated stem cells in response to local stimuli in vivo, while others were not able to 
show this effect[68-70]. 
Stem cells can also be transplanted in vivo after in vitro transdifferentiation into SC-
like phenotypes and/or neurons. The transdifferentiation of stem cells depends on multiple 
interacting factors in their microenvironment, including biological, chemical, physical, 
mechanical and structural cues which, in combination, result in complicated differentiation 
behavioral outcomes [71-78]. The in vitro chemical/biological stimuli-based transdifferentiation, 
involving the use of costly chemicals and growth factors, is the most commonly used 
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strategy. These transdifferentiation procedures involve exposure to combinations of 
chemicals and growth factors, such as, β-mercaptoethanol, all-trans retinoic acid, fetal 
bovine serum, forskolin, recombinant human bFGF, recombinant human platelet-derived 
growth factor-AA, and recombinant human heregulin β-1 depending on the specific cell 
lineage.[79-81] Although chemical induction-based transdifferentiation procedures work with 
high success rates, the cellular mechanisms and signaling pathways dominating the 
differentiation have not been elucidated in detail yet. A very recent study by Sharma et al.[51] 
conducted a detailed proteomic analysis upon MSCs transdifferentiation into SCs via 
chemical induction. Their results revealed that proteins involved in axonal guidance [82], 
vascular endothelial growth factor (VEGF) signaling [83], neuregulin and platelet-derived 
growth factor (PDGF) [84, 85] and IL-1, IL-8 and TNFR1 signaling [86, 87], were significantly 
regulated upon MSC transdifferentiation. Similarly, Jori et al.[88] investigated the molecular 
mechanisms behind the transdifferentiation of MSCs into neurons. Their findings suggested 
that the classical PKA pathway was activated through the guanine nucleotide exchange 
factor for the small GTPase Rap1 and Rap2 as a result of an increase in cAMP, which 
induced MSCs differentiation. The observed MEK–ERK signaling also contributed to neural 
commitment and differentiation of MSCs whereas CaM KII activity did not influence the 
neuronal differentiation significantly.  
Considering the positive influence of electrical stimulation in neural and axonal 
regeneration, the effect of combined chemical and electrical stimuli or only electrical stimuli 
on somatic stem cell transdifferentiation has also been recently investigated. [89-95] The effect 
of various electrical parameters including, voltage, frequency and electrical field strength, on 
stem cell differentiation was investigated using various conductive scaffolds. However, there 
is no detailed mechanistic study describing the electrical stimuli based differentiation of stem 
cells in the literature. It was only hypothesized and reported that the promoted stem cell 
differentiation via electrical stimuli could result from the upregulation of specific signaling 
pathways including focal adhesion kinase (FAK) or mitogen-activated protein kinase 
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signaling (p38)[91, 96-100], MAPK, PI3K, ROCK[92, 101] and ERK pathway as well as the alteration 
of cellular membrane potential via hyperpolarization and/or depolarization, modification of 
ion channels, calcium channel activation[102-104] or the increase in intracellular reactive 
oxygen species (ROS) generation.[92, 105] For instance, Park et al.[92] proposed that 
electromagnetic fields (EMF) induce NADH oxidase activation that generates reactive 
oxygen species (ROS) at the plasma membrane. The increased ROS further phosphorylates 
EGFR which in turn leads to CREB activation through PI3K/Akt pathway. They hypothesized 
that the EMF-induced CREB phosphorylation can promote neuronal differentiation of BM-
MSCs. 
In addition to these different inductive stimuli, the significant effect of mechanical and 
structural properties of scaffolds on the transdifferentiation ability of the stem cells has also 
been investigated. [72, 77, 106-110] It was reported that matrix stiffness can regulate the 
transdifferentiation of MSCs into specific lineages, indicating that softer substrates promote 
neurogenic, adipogenic and chondrogenic fates, while stiffer substrates enhance 
myogenesis and osteogenesis.[72, 78, 110-115] Moreover, the culturing and transdifferentiation of 
stem cells on 3D scaffolds with controllable structural properties mimicking an ECM 
microenvironment has also shown to be a better approach than using traditional 2D tissue 
culture plates.[116] Although the effect of mechanical cues on differentiation is known, further 
investigation regarding the cellular mechanisms and related signaling pathway analysis is 
needed in order to understand the stem cell differentiation behavior. The mechanism of 
stiffness-mediated transdifferentiation of stem cells is considered to be associated with the 
communication between mechanical and biochemical signals which are based on integrins. 
The focal adhesions, such as focal adhesion kinase (FAK), are key proteins regulating the  
intracellular signaling mechanisms/pathways. Any potential mechanical stimulation causes 
conformational change of signaling molecules/proteins resulting in opening phosphorylation 
sites, kinase cascades activation, transport of intracellular signaling molecules and changes 
in gene expression.[116] For instance, Du et al.[117] reported that soft substrates modulated the 
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neurogenic differentiation of MSC by blocking the BMP/Smad signaling pathway through β1 
integrin internalization. They observed an increase in the active form of β1 integrin in MSCs 
on soft substrates. The detachment of integrin-ECM protein complexes also increased 
leading to a decrease in the cell surface distribution of β1 integrin in MSCs. This situation 
brought about the activated integrin internalization through caveolae/raft dependent 
endocytosis, which further enhances the membrane localization of BMP receptor (BMPR). 
Following the endocytosis, the binding efficiency of BMPR to the ligands starts to decrease 
resulting in the inhibition of Smad 1/5/8 phosphorylation. This further leads to the expression 
of neuronal genes, including microtubule associated protein 2, neurofilament protein light 
chain and nestin.  
In addition to the mentioned stimuli controlling the transdifferentiation, recently the 
positive effect of ultrasound on stem cell transdifferentiation was also reported. This study 
showed enhanced cell viability, proliferation and neural differentiation along with up-
regulated gene and protein expressions in induced pluripotent stem cells–derived neural 
crest stem cells (iPSCs–NCSCs).[118]  
The potential positive effects of transdifferentiation on in vivo viability, enhanced 
neurotrophic factor secretion, myelination, axonal growth and regeneration have been 
demonstrated.[18, 95, 119-123]  However, it is difficult to maintain the in vitro differentiated state of 
the stem cells under dynamic in vivo conditions.  
It was previously reported that in vitro transdifferentiated cells have a tendency to 
revert back to their original phenotype once in vitro transdifferentiation cues are removed 
under in vivo conditions.[124] Direct comparisons in the literature have portrayed either a 
small advantage for transdifferentiated cells [121, 125], a small advantage for undifferentiated 
cells[68, 126] or no significant differences[53, 57]. Although the necessity of transdifferentiation 
prior to transplantation has been hypothesized for the best outcomes, the fate commitment 
of transdifferentiated stem cells is still posing an issue to the clinical applicability of the direct 
transplantation of undifferentiated cells.[127] For instance, Walsh et al.[127] reported that in vivo 
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transplanted skin-derived precursor cells (SKPs) can differentiate into myelinating Schwann 
cells  by responding to local cues and stay in the transplanted area for a minimum of 10 
weeks. They noted that the fate of SKPs in vivo depends on the nerve environment and can 
be modified by inclusion of heregulin-1β.  
In another approach, Shea et al.[128] observed that bone marrow-derived MSCs, 
transdifferentiated into SCs, were able to maintain their differentiated state in co-culture with 
neurons purified from embryonic dorsal root ganglia. They further proved that the cells 
continued to maintain their status even without exogenous transdifferentiation-inducing 
factors or neurons. On the other hand, Faroni et al.[129] observed that the withdrawal of 
transdifferentiation medium resulted in a rapid reversion from SCs back to stem cell-like 
characteristics for transdifferentiated adipose-derived stem cells. This was accompanied by 
significant reduction in gene and protein expression of growth factors for SC-like 
phenotypes. In contrast, Zhang et al.[130] injected Schwann-like cells generated via in vitro 
transdifferentiation of adipose-derived stem cells into a sciatic nerve lesion area after crush 
injury in vivo. They observed transdifferentiated cells throughout the sciatic nerve injury site 
up to 12 weeks after transplantation, while a small fraction of the cells differentiated into 
fibrocyte/fibroblast-like cells.   
Considering these conflicting results present in the literature, efficient and scalable 
transdifferentiation procedures enabling successful differentiation and precise control of the 
final fate of the implanted cell population along with the design of multifunctional NGCs that 
mimic the complex ECM microenvironment are needed for desired stem cell-based neural 
regeneration therapy. A detailed summary of recent studies in the literature regarding 
transdifferentiation strategies and cellular mechanisms along with the use of nerve guidance 
conduit designs is presented in the following sections.  
 
3. Nerve Guidance Conduit Designs and Materials  
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The transplantation or delivery of transdifferentiated or undifferentiated stem cells 
through nerve guidance conduits (NGCs) holds considerable potential for successful nerve 
regeneration. Proper material selection along with efficient implantable NGCs production 
methods and design strategy, involving various combinations of biological/chemical, physical 
and mechanical cues, should be considered to mimic the natural microenvironment of ECM 
for cell survival, growth, proliferation, and differentiation to achieve efficient nerve 
regeneration (Figure 1).[38, 52, 131-134]  
The selected NGC material should be biocompatible and the degradation rate should 
be consistent with the nerve regeneration rate to allow sufficient support during the 
regeneration process.[52, 131, 132] The conduit microstructure should possess proper pore size, 
porosity and swelling ratio along with desired mechanical properties to allow efficient nutrient 
diffusion and limit scar tissue infiltration.[5, 135-137]  In addition, this will allow available 
microenvironments supporting the cells capable of secreting neurotrophic factors at the site 
of regeneration.[122, 137] The NGC should be able to provide cues such as longitudinal 
micropatterns or growth factor gradients to provide directional guidance. [14, 19, 23, 137-141] It is 
also important for a NGC to be eligible for protein modification to increase cellular 
attachment or controlled/sustained growth factor release to mimic the ECM 
microenvironment.[137, 142-146] Another important consideration is the physical size of the 
conduit, which should have a sufficiently large internal diameter with proper wall thickness to 
provide available space for the regenerating nerve and for straightforward handling during 
surgery.[3, 147] In addition to these parameters, considering the inherent ability of neuronal 
cells to send electrical signals along axons, it is also important to have an electrically 
conductive NGC that is capable of propagating electrical signals to promote stem cell 
differentiation, function and neural regeneration.[148-150] The NGCs possessing the mentioned 
features can be produced through many well-defined techniques, including immersion 
precipitation particulate leaching[151], extrusion [152, 153], injection molding[154, 155], non-woven or 
woven mesh rolling[156, 157], centrifugal casting[158], spinning mandrel technology[159], film 
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casting plus rolling[14, 19, 137], spin casting plus dry-phase inversion[137], and molding plus 
freeze drying[122]. Some advanced fabrication techniques have also been developed for 
preparing scaffolds with more complex configurations, such as a multichannel NGCs[160, 161], 
or NGCs containing longitudinally aligned fibers[162], micro-grooves[40] or hydrogels[163] within 
their lumens.  
A wide variety of biomaterials, mostly including natural (gelatin, collagen, chitosan, 
fibrin etc.), synthetic polymers (poly(lactide acid) (PLA), poly(glycolic acid) (PGA), poly(lactic-
co-glycolic acid) (PLGA), polycaprolactone (PCL), polyhydroxybutyrate (PBH) etc.),  carbon-
based conductive materials and their unique combinations, have been tested to promote 
stem cell differentiation and functional recovery of injured nerves as discussed in detail in 
previous reviews.[32, 38, 131, 132]  [3, 147]  
 
Figure 1. Conduit properties.[132] Illustration by Rose Perry. Copyright 2013, Woodhead 
Publishing.  
 
4. Direct In vivo Stem Cell Transplantation and in situ Differentiation  
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The direct in vivo transplantation of undifferentiated stem cells via injection or via conduits 
made from various materials and possessing different features has been considered as a 
practical and clinically translational approach for PN injury repair. The transplanted stem 
cells have the potential to induce the production of in situ molecules and modulate the local 
environment for the reduction of inflammation and promotion of axonal regeneration through 
direct or indirect cross-talk with local glial cells. In addition, upon transplantation, these stem 
cells have a tendency to go through a process of transdifferentiation into different lineages 
as a result of synergetic interactions with their local environment. A summary of the studies 
using direct in vivo stem cell transplantation and in situ differentiation is summarized in Table 
1.  
 
 
Table 1. Summary of direct in vivo transplantation of stem cells and in situ differentiation. 
Conduit/Scaffold 
Type 
Stem Cell 
Source 
Differentiation 
Method 
Outcome Reference 
Acellular conduit 
made from a 
separated 
esophageal 
submucous 
membrane 
Mouse skeletal 
muscle-derived 
multipotent 
stem cells (Sk-
MSCs) 
In vivo 
transplantation 
and in situ 
differentiation 
In situ differentiation of 
Sk-MSCs into SCs and 
perineurial/endoneurial 
cells leading to 
enhanced axonal 
regeneration. 
Tamaki et 
al.
[66]
 
Acellular vein filled 
with a small piece of 
fresh muscle 
Bone marrow-
derived stromal 
cells (BMSCs) 
In vivo 
transplantation 
and in situ 
differentiation 
Enhanced regeneration 
accompanied by the in 
situ differentiation of 
BMSCs into SCs after 
the implantation. 
Nijhuis et 
al.
[56]
 
Autologous vein 
conduit filled with 
fibrin scaffold 
Human 
adipose tissue-
derived 
mesenchymal 
stem cells 
(hAdMSCs) 
In vivo 
transplantation 
and in situ 
differentiation 
Xenotransplantation of 
hAdMSCs into a fibrin 
scaffold promoted nerve 
regeneration in the 
peroneal nerve of 
rabbits, however no sign 
of differentiation was 
reported. 
Lasso et 
al.
[126]
 
Genipin-cross-linked 
gelatin conduit 
annexed with 
Adipose tissue-
derived stem 
In vivo 
transplantation 
and in situ 
Demonstrated in situ 
neuronal differentiation 
Shen et 
al.
[65]
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tricalcium phosphate 
ceramic particles 
cells (ADSCs) differentiation of ADSCs. 
Chitosan conduit 
with different degree 
of deacetylation and 
molecular weight 
Bone marrow-
derived 
mesenchymal 
stem cells 
(BMSCs) 
In vivo 
transplantation 
and in situ 
differentiation 
Chitosan conduit with 
95% degree of 
deacetylation and 
molecular weight of 106 
Da promoted the 
survival and outgrowth 
of cells, as well as 
differentiation of BMSCs 
into neural stem cells 
which induce bridging of 
8-mm-long neural gap in 
vivo. 
Zheng et 
al.
[63]
 
Multi-channel 
chitosan conduits 
BMSCs In vivo 
transplantation 
and in situ 
differentiation 
Enhanced nerve 
regeneration through 
the in vivo differentiation 
of BMSCs as efficient 
as nerve allografts in 
bridging the large gap in 
sciatic nerves of adult 
rats.  
Zheng et 
al.
[67]
 
Collagen based 
conduits 
Mobilized 
dental pulp 
stem cells 
(MDPSCs) 
In vivo 
transplantation 
and in situ 
differentiation 
Implanted MDPSCs 
promoted axon 
regeneration through 
trophic activity acting on 
Schwann cells and 
promoting 
angiogenesis. No direct 
differentiation into SCs 
reported. 
Yamamoto 
et al.
[164]
 
Gelatin hydrogel 
tubes 
ADSCs In vivo 
transplantation 
and in situ 
differentiation 
ADSCs transplantation 
promoted regeneration 
of axons, formation of 
myelin, and restoration 
of denervation muscle 
atrophy to levels 
comparable to those 
achieved by SCs 
transplantation. Cells 
survived for at least 4 
weeks after 
transplantation without 
differentiating into SCs. 
Sowa et 
al.
[58]
 
Fibrin glue conduit BMSCs In vivo 
transplantation 
and in situ 
Implanted MSCs 
enhanced axonal 
regeneration only when 
cyclosporine A 
McGrath et 
al.
[165]
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differentiation treatment was applied. 
No differentiation 
observed. 
Poly-3-
hydroxybutyrate 
(PHB) sheets 
ADSCs In vivo 
transplantation 
and in situ 
differentiation 
No in situ differentiation 
of ADSCs was noted; 
however, the 
regenerative effect was 
attributed to released 
growth factors and/or 
indirect effect on 
endogenous SCs 
activity. 
Erba et al.
[53]
 
Polycaprolactone 
(PCL) based 
conduits 
BMSCs In vivo 
transplantation 
and in situ 
differentiation 
Significantly improved 
the median nerve 
regeneration after a 
traumatic lesion 
suggesting that 
transplanted cells may 
occasionally 
transdifferentiate into 
SCs. 
Oliveira et 
al.
[166]
 
Poly (DL-lactide-e-
caprolactone) 
copolyester based 
commercial conduit 
(Vivosorb, PLC) 
Wharton’s jelly 
derived 
mesenchymal 
stem cells (WJ-
MSCs) 
In vivo 
transplantation 
and in situ 
differentiation 
No differentiation of WJ-
MSCs into nerve 
structure was observed; 
however, enhanced 
regeneration 
accompanied by 
upregulation of 
expression for netrin-1, 
ninjurin, BDNF, GDNF, 
VEGF and angiopoitin-1 
rat genes was reported. 
Shalaby et 
al.
[167]
 
Micropatterned 
poly(L-lactic acid) 
(PLA) nerve conduit 
Neural stem 
cells (NSCs) 
In vivo 
transplantation 
and in situ 
differentiation 
Increased levels of 
IL12p80 triggering 
NSCs to SCs 
differentiation through 
Stat3 phosphorylation 
and enhanced 
functional and motor 
recovery. 
Lee et al.
[168]
 
Microstructured 
poly-caprolactone 
(PCL) filaments 
BMSCs Co-culture with 
SCs followed by 
in vivo 
transplantation 
and in situ 
differentiation 
Demonstrated good 
axonal regeneration, 
myelination and 
reinnervation; however, 
no differentiation of 
MSCs into glial lineage.   
Carrier-Ruiz 
et al.
[169]
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Local[170-172] and systemic[39, 171] administration of stem cells from different sources 
have been applied in order to enhance PN regeneration. It was reported that local injection 
exhibited significant increase in axonal fiber counts while systemic treatment resulted in 
improved nerve regeneration and pronounced electromotor recovery. [171] Although the 
injected stem cells (regardless of the injection method) showed immune modulatory effects, 
synergistically supported local Schwann cells, and enhanced PN regeneration with functional 
recovery through secretion of neuroprotective factors, their differentiation behavior was not 
consistent. Some studies reported efficient in situ differentiation of injected stem cells into 
various lineages[172] while the others did not observe any differentiation.[39, 170] Therefore, 
there is still uncertainty about the differentiation potential into specific lineages and 
maintaining the differentiated states long-term. Nevertheless, there is a therapeutic potential 
of the injected stem cells.  
As an alternative to direct injection, the implantation of stem cells along with NGCs 
promotes the regeneration of damaged nerves by supporting and guiding axonal growth 
between nerve stumps and retaining neurotrophic factors, while preventing fibrous tissue 
ingrowth. In addition, the implanted stem cells can potentially differentiate into Schwann cells 
and provide a microenvironment enriched with growth factors, promoting nerve regeneration. 
Considering this, recent studies have used acellular esophageal submucous membrane[66] or 
vein conduits filled with fresh muscle[56] or fibrin scaffolds[126] bearing stem cells from various 
sources for cell implantation (see Table 1). Most of these studies demonstrated enhanced 
axonal regeneration using acellular conduits with stem cells; though only some studies 
observed in situ differentiation.[56, 66] Although acellular conduits are promising candidates to 
mimic an ECM microenvironment and support nerve regeneration and cell differentiation, 
their limited availability is still a challenge to their wide scale implementation.  
Alternatively, bioengineered conduits with various properties made from natural 
biopolymers, synthetic polymers or combinations of the two were also used for direct 
implantation of undifferentiated stem cells. Chitosan conduits, with 95% degree of 
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deacetylation, possessing multi-channels were reported to promote the survival and 
outgrowth of cells, enhanced nerve regeneration as well as in vivo differentiation of BMSCs 
into neural stem cells.[63, 67] Chitosan was also used in combination with other biopolymers 
(chitosan/ silk fibroin scaffolds[70] or synthetic polymers (chitosan/PLGA[68, 69]) for different 
conduit designs providing efficient regeneration as in autografts. However, none of these 
studies reported in situ differentiation of stem cells. Similarly, other studies used different 
sources of stem cells with various conduits made from natural biopolymers (i.e. collagen 
based conduits[164], gelatin hydrogel tubes[58], fibrin glue conduit[165]) for in vivo implantation 
targeting nerve regeneration. All of these studies reported the localization of undifferentiated 
stem cells near SCs induced with several neurotrophic factors and the subsequent 
proliferation and migration of resident SCs that resulted in enhanced regeneration of axons, 
myelinated fibers, and revascularization. Some studies claimed that transplanted stem cells 
enhance homing and migration of endogenous cells to the injured site for remyelination 
through the stromal cell-derived factor (SDF-1)/CXCR4 signaling as reported in injured 
central nervous system.[164] Another study hypothesized that cyclosporine A, an 
immunosuppressive agent with known neuroprotective potential, promotes 
neuroregeneration and neuronal extension via induction of GAP-43 through the inhibition of 
romatase and calcineurin activity when stem cells implanted without immunosuppresion.[165]  
However, very few studies observed the differentiation of implanted stem cells into 
different lineages. For instance, Shen et al.[65] demonstrated in situ neuronal differentiation of 
adipose tissue-derived stem cells (ADSCs) when transplanted in genipin-cross-linked gelatin 
conduits annexed with tricalcium phosphate ceramic particles. However, they did not 
conduct any study to elucidate the cellular mechanism of in situ differentiation.   
The use of conduits made from different synthetic polymers, either alone or in 
combination (i.e. (Poly-3-hydroxybutyrate (PHB)[53], microstructured poly-caprolactone 
(PCL)[169], poly (DL-lactide-e-caprolactone) copolyester based commercial conduit (Vivosorb, 
PLC)[167]) with stem cells also promoted nerve regeneration, myelination and reinnervation 
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through released growth factors, indirect effect on endogenous SCs activity or upregulation 
of expression for certain genes or pathways such as netrin-1, ninjurin, BDNF, GDNF, VEGF 
and angiopoitin-1. However, they did not enhance the in situ differentiation potential of the 
transplanted stem cells. On the other hand, some studies reported occasional 
transdifferentiation of MSCs and NSCs into Schwann cells on implanted polycaprolactone 
(PCL)[166] and micropatterned poly(L-lactic acid) (PLA)  based nerve conduits[168] (Figure 2), 
respectively. Based on the previous reports indicating the effect of Stat3 phosphorylation on 
astroglial differentiation of NSCs[173], Lee et al.[168] hypothesized and showed that IL12p80 
could trigger differentiation of NSCs into Schwann cells through Stat3 activation, where 
IL12p40 subunit can bind to IL12 receptor β1 and then induce Stat3 phosphorylation and the 
downstream signaling pathway. 
 
Figure 2. (A) Immunohistochemistry of regenerated sciatic nerve sections. The Conduit only 
group “A” showed less integration of regenerated axon than the Conduit + NSC group “B” 
and Conduit + NSC + mIL12 group “C”. The failure of axon regeneration in the Conduit only 
group “D” was observed whereas myelinating Schwann cells (PZO positive cell) coupling 
nerve fiber (NF200 positive cell) existed in the medial region of conduits in the Conduit + 
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NSC “E” and in the Conduit + NSC + mIL12 groups “F”. (B) The schematic diagram of 
regeneration and quantitative results of regenerated nerve diameter at different sites. The 
regenerated nerve diameter was the highest in Conduit + NSC + mIL12 groups in the medial 
site. (C) Immunocytochemistry results. (D) Quantification of marker-positive cells. 
Immunocytochemistry staining and quantification results showed that IL12p80 could replace 
CNTF+T3 to induce Schwann cell differentiation of mouse NSCs. Reproduced with 
permission.[168] Copyright 2017, Elsevier.  
 
5. Stem Cell Differentiation Using Chemical Induction  
On 2D-Tissue Culture Plates 
The growth of permissive Schwann cells (SCs), which are myelinating cells of PNS, 
form a myelin sheath around peripheral axons and produce extracellular matrix (ECM) 
molecules, integrins and neurotrophic factors, enhance guidance and provide support for 
regenerating axons.[6-9, 11, 174] The chemical stimuli-based transdifferentiation of stem cells 
into SC-like phenotypes was first conducted on regular 2D tissue culture plates as 
summarized in Table 2. 
 
 
Table 2. Summary of direct transdifferentiation using chemical stimuli or conditioned media 
approach. 
Conduit/Scaffold 
Type 
Stem Cell 
Source 
Differentiation 
Method 
Outcome Reference 
2D tissue culture 
plates 
Adipose tissue-
derived stem 
cells (ADSCs) 
Regularly used 
chemical induction 
based 
transdifferentiation 
Transdifferentiation 
into SCs with ~95%. 
Demonstrated that 
SCs-like cells derived 
from ADSCs can 
undergo mitotic 
proliferation. 
Fu et al.
[175]
 
2D tissue culture 
plates 
ADSCs Olfactory 
ensheanthing cell 
conditioned 
medium based 
Successfully 
differentiate ADSCs 
into SCs. 
Xie et al.
[176]
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transdifferentiation 
2D tissue culture 
plates 
Neural stem 
cells (NSCs) 
DMEM/F12 
supplemented with 
forskolin, heregulin, 
bFGF, PDGF-AA 
and retinoic acid 
(RA) 
Reported successful 
differentiation of 
NSCs into SCs 
exhibiting a spindle-
like morphology and 
expressing the glial 
markers p75 and 
S100. Differentiated 
NSCs with enhanced 
neurite outgrowth of 
co-cultured NG108-15 
cells. 
Tong et 
al.
[177]
 
2D tissue culture 
plates 
Bone marrow-
derived 
mesenchymal 
stem cells 
(BMSCs) 
Lesioned 
microenvironment 
of the injured nerve 
by obtaining 
different extracts 
from the distal 
segment (Ds) and 
proximal segment 
(Ps) of degenerated 
rat sciatic nerves 
Cells cultured with Ds 
extracts had 
significantly higher 
neural marker 
expression than that 
of cells cultured with 
Ps extracts and the 
untreated cells. The 
results showed SC-
like differentiation. 
Wang et 
al.
[178]
 
2D tissue culture 
plates 
ADSCs Induction medium 
obtained by 
soaking cut rat 
sciatic nerve in 
culture medium for 
two days to extract 
the factors and 
agents  
Observed a spindle 
shape like 
morphology and 
expression of the 
typical SCs markers 
upon induction 
proving successful 
differentiation. 
Liu et al.
[179]
 
2D tissue culture 
plates 
Muscle-derived 
stem cells 
(MDSCs) 
SC-conditioned 
medium 
Differentiation of stem 
cells can be either 
manipulated using 
SC-conditioned 
medium or combined 
treatment of 
neurotrophic factors 
(PDGF, NT-3 and 
IGF-2) identified in 
the SC-conditioned 
medium giving the 
similar results. 
Tang et 
al.
[180]
 
2D tissue culture 
plates 
ADSCs Dissociation of 
nestin-positive non-
adherent 
neurosphere 
cellular aggregates 
SC-like differentiation 
providing expression 
of the characteristic 
SCs markers S100, 
p75 and GFAP and 
Radtke et 
al.
[181]
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produced from 
ADSCs cultured 
with bFGF and 
EGF and removal 
of mitogens 
stimulated neurite 
outgrowth when co-
cultured with dorsal 
root ganglion 
neurons. 
2D tissue culture 
plates 
Tonsil-derived 
mesenchymal 
stem cells (T-
MSCs) 
Inducing T-MSCs to 
form neurospheres 
and incubating 
them with bFGF, 
EGF, and B27 
supplement 
Differentiation into 
SC-like cells and 
promoted myelination 
and regeneration of 
damaged nerves. 
Jung et 
al.
[182]
 
2D tissue culture 
plates 
BMSCs Infection of rat 
BMSCs by 
recombinant 
lentiviruses to 
obtain tropomyosin 
receptor kinase A 
(TrkA)-
overexpressing 
BMSCs followed by 
direct transplantion 
using acellular 
grafts into rat 
sciatic nerve 
defects 
Reported high degree 
of differentiation into 
SCs with the highest 
cellular survival 
compared to all other 
control groups 
Zheng et 
al.
[183]
 
2D tissue culture 
plates 
Human 
pluripotent stem 
cells (hPSCs) 
Combined 
sequential 
treatment with 
inhibitors of the 
TGF-β and GSK-3 
signaling pathways, 
with neuregulin-1 
hPSCs differentiated 
into immature SCs 
that were functionally 
confirmed by their 
secretion of 
neurotrophic factors 
and their myelination 
capacity in vitro and 
in vivo. 
Kim et al.
[184]
 
2D tissue culture 
plates 
BMSCs Chemical 
stimulation based 
on epidermal 
growth factor 
(EGF), basic 
fibroblast growth 
factor (bFGF), 
neurobasal medium 
supplemented with 
N2 and B27, 
retinoic acid and 
sonic hedgehog 
Reported successful 
NC-like differentiation 
and concluded that 
differentited cells 
could protect the 
disintegration and 
destruction of the 
injured peripheral 
nerve. 
Guo et al.
[24]
 
2D tissue culture Human adipose 
derived stem 
Inhibited the 
activin/nodal/TGF-𝛽 
Reported formation of 
neurite extensions, 
Madhu et 
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plates cells (hADSCs) and BMP pathways 
using SB431542 
and dorsomorphin, 
respectively 
protein expression of 
neuron-specific 
gamma enolase, and 
mRNA expression of 
neuron-specific 
transcription factors 
and matured neuronal 
marker. 
al.
[26]
 
 
 
 
Dezawa et al.[16] were one of the first demonstrating the differentiation of bone 
marrow derived MSCs into SCs using a treatment based on exposure to beta-
mercaptoethanol followed by retinoic acid and cell culturing in the presence of forskolin, 
basic-FGF, PDGF and heregulin. Following this study, other groups used similar protocols 
with minor modifications to achieve differentiation of adult stem cells from different sources 
(mostly bone marrow[20, 21, 178, 183] or adipose [46, 119, 175, 176, 179, 181, 185], human umbilical cord[186], 
muscle-derived stem cells (MDSCs)[180], tonsil-derived mesenchymal stem cells (T-
MSCs)[182], human pluripotent stem cells (hPSCs)[184] and neural stem cells (NSCs)[177]) into 
SC-like phenotypes (see Table 2). For instance, in recent studies, differentiation of adipose 
derived stem cells (ADSCs) into SCs was obtained either using classical protocols 
mentioned above[175] or using olfactory ensheathing cell conditioned medium.[176] It was 
hypothesized that activation of the mitogen‑activated protein kinase/extracellular 
signal‑ regulated kinase signaling pathway and/or inhibition of the caspase pathway 
regulates MSCs to SC differentiation.[16, 175, 177] These studies also briefly described the roles 
of each cytokine used to differentiate stem cells into Schwann-like cells. β-ME increases the 
glutathione synthesis and reduces the cell response to oxygen tension. ATRT regulates the 
expression of cell surface receptors, retinoic acid receptors, retinoid X receptors and certain 
factors critical to the development of neural cell differentiation. HRG, a subtype of 
neuregulin, prevent apoptosis of SC precursors, induces neural crest differentiation into SCs 
selectively and acts on axonal signaling and myelination. FSK elevates the level of 
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intracellular cAMP which can mimic SC responses in the presence of axons during 
myelination in vivo. bFGF regulates MSC differentiation into the SC phenotype by involving 
in cell growth and differentiation.  
Xie et al.[176] stated that secretion of growth factors and cell adhesion molecules 
constitutes the underlying mechanism of stem cell differentiation. Considering that 
SB431542, a small molecule inhibitor of the TGF-/activin/Nodal pathway, is actively 
involved in cytokine- mediated cell proliferation and differentiation, they reported that 
blockade of TGF- signaling can trigger differentiation of stem cells into neural cells. 
Although multipotent NSCs have the potential to differentiate into various cells of 
neural lineage (neurons, astrocytes and oligodendrocytes) their differentiation into SCs has 
been rarely investigated. In the study of Tong et al.[177] the differentiation of NSCs into SCs 
was demonstrated using a slightly modified method of Dezawa et al.[16]. In general, these 
studies observed significant morphological changes, immunolabeling of various SC markers 
(i.e., p75, S100, GFAP, O4, etc.), regulated genes and proteins, and enhanced paracrine 
activity upon differentiation, thus supporting successful transdifferentiation. The biological 
activity of the secreted neurotrophic factors, such as NGF, GDNF, BDNF etc., was confirmed 
using a non-contact cell co-culture model with differentiated stem cells, DRGs or PC12 cells 
that can show neurite extension upon contact with the neurotrophic factors secreted from 
transdifferentiated MSCs.  However, other studies have used different approaches to ensure 
differentiation of stem cells into SC-like phenotypes.  
Based on the previously reported results indicating the potential for in vivo 
differentiation of transplanted stem cells into functional Schwann-like cells, some studies 
tried to mimic the lesioned microenvironment of the injured nerve by obtaining an induction 
medium through the extraction of factors and agents from the distal and proximal segment of 
degenerating rat sciatic nerves[178] or from the cut rat sciatic nerve soaked in culture 
medium[179] or directly using SC-conditioned medium.[180] These studies suggested that 
specific trophic factors secreted from sciatic nerve leachate or from the microenvironment of 
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the nerve lesions, were capable of inducing MSCs or ADSCs to differentiate into functional 
Schwann-like cells, which may potentially originate from the distal segment of the 
degenerated nerve, as in the case of regularly applied transdifferentiation protocol of 
combined neurotrophic factors (Figure 3).[178, 180] However, they stated that the mechanisms 
by which MSCs differentiate into Schwann cells in vivo and their functions are still uncertain. 
 
Figure 3. (A) Detection of the protein levels of Schwann cell markers in MSCs. (B) mRNA 
expression of Schwann cell markers in MSCs. The cells cultured with distal segment (Ds) 
extracts had significantly higher expression of glial fibrillary acidic protein (GFAP), Sox10, 
Oct6, and early growth response 2(Egr2) than that of cells cultured with proximal segment 
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(Ps) extracts and the untreated cells. Reproduced with permission.[178] Copyright 2013, 
Elsevier.  
 
As another strategy, dissociation of neurospheres generated from adipose-derived 
mesenchymal stem cells[181] or tonsil-derived mesenchymal stem cells (T-MSCs)[182]  by 
culturing with different factors (i.e. bFGF, EGF, and B27 supplement), and subsequent 
mitogen withdrawal was used to obtain SC-like phenotypes. The SC-like transdifferentiated 
stem cells promoted myelination and regeneration of damaged nerves in an in vivo mouse 
model of sciatic nerve injury. [182] They also hypothesized that the stem cell differentiation is 
mediated via stimulating the MEK-ERK1/2 and PI3K-AKT pathways. 
Specific receptors, inhibitors or signaling pathways have also been targeted for stem 
cell differentiation. For instance, considering that tropomyosin receptor kinase A (TrkA) is 
absent in un-differentiated BMSCs but is expressed in neurally differentiated BMSCs, Zheng 
et al.[183] transduced rat BMSCs with recombinant lentiviruses to obtain TrkA-overexpressing 
BMSCs, which were then transdifferentiated into SCs upon transplant into rat sciatic nerve 
defects via acellular nerve grafts. They expressed the mechanism of differentiation based on 
NGF binding to TrkA, which leads to receptor dimerization and kinase activation. After 
phosphorylation, tyrosine Y490 creates sites for adaptor protein Shc while tyrosine Y785 
creates sites for phospholipase C-γ1 (PLC-γ1). These receptors are then further involved in 
intracellular signaling cascades, including the Ras/Erk protein kinase pathway, the 
phosphatidylionsital-3-OH kinase (PI3K)/Akt kinase pathway and PLC-γ1 pathway regulating 
NGF/TrkA dependent cell survival and differentiation.  
As another approach, combined sequential treatment with inhibitors of the TGF-β 
and GSK-3 signaling pathways, and with neuregulin-1 to differentiate human pluripotent 
stem cells (hPSCs) into self-renewing Schwann cell precursors (SCPs) and further into 
immature Schwann cells was used. [184] Their results indicated that NRG1-ErbB signaling, 
which leads to the activation of complex intracellular signaling pathways, such as MAPK, 
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phosphatidylinositol 3-kinase, or PLCg, and subsequent gene expression in SCs, is a key 
directional cue to drive SC fate specification of a plastic intermediate state of hPSC 
differentiation and that it depends on the function of SOX10. In a very recent study, Bierlein 
De la Rosa et al. [187] transdifferentiated genetically modified BDNF hypersecreting 
mesenchymal stem cells into SC-like phenotypes with 30-50% degree of differentiation using 
both genetic modification and conventional transdifferentiation techniques.  
Beside SC-like phenotypes, it was also demonstrated that neural cell-like phenotypes 
also show potential for effective repair of peripheral nerve defects by providing protection of 
peripheral nerve injuries, reduced lesions, and improved recovery, though the mechanism of 
neural-like cells in the peripheral nerve is still unclear. Therefore, adult stem cells (BMSCs or 
ADSCs) were also differentiated into neural cell (NC)-like phenotypes possessing 
characteristics of neurons using chemical stimulation based on EGF, bFGF, Neurobasal 
medium supplemented with N2 and B27, retinoic acid and sonic hedgehog on 2D tissue 
culture plates[24] or inhibition of activin/nodal/TGF-𝛽 and BMP pathways using SB431542 and 
dorsomorphin, respectively.[26] These studies demonstrated significant immunolabeling with 
NC markers, such as NeuN, MAP2, Nestin, anti-𝛽-III tubulin etc., mRNA expression of 
neuron-specific transcription factors Sox1 and Pax6 and mature neuronal marker NF200. 
 
In vitro Co-culture 
The use of dynamic in vitro co-culture models, simulating the in vivo conditions and 
synergistic interactions, is another strategy for stem cell differentiation (Table 3). 
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Table 3. Summary of direct transdifferentiation using co-culture approach. 
Conduit/Scaffold 
Type 
Stem Cell 
Source 
Differentiation 
Method 
Outcome Reference 
2D tissue culture 
plates 
Bone marrow-
derived  
mesenchymal 
stem cells 
(BMSCs) 
Co-cultured 
BMSCs with SCs 
using a Millicell 
system 
More than 75% of the 
BMSCs were SCs 
marker positive during 
co‑ culture although 
they were observed to 
loss typical SC‑ like 
morphology and revert 
back to their native 
appearance after 3 
days of co-culture. 
Zhou et 
al.
[188]
 
2D tissue culture 
plates 
Adipose tissue-
derived stem 
cells (ADSCs) 
Either chemical 
induction or co-
culture with SCs in 
transwell culture 
dishes 
Both differentiation 
method showed 
similar degree of 
differentiation 
confirmed by the 
detection of S100, 
nestin and GFAP 
markers/genes, 
suggesting that co-
culturing ADSCs and 
SCs may be a simple, 
effective and practical 
way for ADSCs 
transdifferentiation. 
Liao et 
al.
[189]
 
2D tissue culture 
plates 
Neural stem 
cells (NSCs) 
Co-culturing SCs 
with NSCs 
High cell survival 
rates, enhanced 
secretion of BDNF 
and GDNF and 
expression of Map2 in 
the co-culture. 
Yu et al.
[190]
 
 
 
 
 
 
Zhou et al.[188] co-cultured bone marrow stromal cells (BMSCs) with Schwann cells (SCs) 
using a Millicell system that allows cell growth in the same culture medium without direct 
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contact. Their results showed that more than 75% of the BMSCs in the indirect co‑ culture 
model were GFAP‑  and S‑100‑positive during co‑ culture, indicating positive 
transdifferentiation into SCs, although they were observed to lose typical SC‑ like 
morphology and revert back to their native appearance after 3 days of co-culture. However, 
they were not able to explain the cellular mechanisms behind the transdifferentiation.  In 
another study, Liao et al.[189] used ADSCs to differentiate them into SCs either through 
chemical induction or co-culture with SCs in transwell culture dishes for comparison of these 
two methods. Their immunostaining and RT-PCR results indicated that both differentiation 
methods showed similar degrees of differentiation confirmed by the detection of S100, nestin 
and GFAP markers/genes, suggesting that co-culturing ADSCs and SCs may be a practical 
approach for neural transdifferentiation of ADSCs. A similar co-culturing strategy was used 
for neural stem cells (NSCs). Yu et al.[190] reported that co-culturing Schwann cells (SCs) 
with NSCs promoted differentiation of NSCs into neurons. This strategy, resulting in high cell 
survival rates, enhanced secretion of BDNF and GDNF and expression of Map2 in the co-
culture, is proposed as a new promising approach (Figure 4).  
 
 
Figure 4. Gene expression for BDNF, GDNF, Map2 and GFAP upon co-culture. Reproduced 
with permission.[190] Copyright 2017, Spandidos Publications.  
 
 
In vitro Transdifferentiation on 2D Plates Followed by Conduit Transplantation  
Following the in vitro transdifferentiation protocols described above (chemical stimulation or 
in vitro co-culture), the differentiated cells were transplanted into animals using NGCs made 
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from various materials, mostly acellular nerve/muscle grafts, biomaterials or synthetic 
polymers (Table 4).  
 
 
 
 
Table 4. Summary of direct transdifferentiation using chemical stimuli, conditioned media or 
co-culture approach followed by transplantation via nerve guidance conduits. 
Conduit/Scaffold 
Type 
Stem Cell 
Source 
Differentiation 
Method 
Outcome Reference 
Acellular muscle 
stuffed vein 
Bone marrow-
derived  
mesenchymal 
stem cells 
(BMSCs) 
Transdifferentiation 
via chemical 
induction on 2D 
tissue culture plates 
35–75% of the cells 
expressed neural 
markers after 
differentiation. 
Seeded cells 
produced a new 
matrix following the 
degradation of 
acellular muscle 
tissue. The vein was 
intact and no 
inflammatory 
reactions were 
observed. 
Hassan et 
al.
[191]
 
Acellular nerve 
xenograft 
Sprague 
Dawley (SD) rat 
hair follicle 
neural crest 
stem cells 
Obtained neurons 
and SCs through 
differentiation of SD 
rat hair follicle 
neural crest stem 
cells with sonic 
hedgehog/retinoic 
acid and 
neuregulin1, 
respectively 
Synergetic effect 
enhanced 
regeneration of 
axons and long-term 
implanted cell 
survival upon 
transplantation. 
Lin et al.
[192]
 
Acellular nerve 
grafts 
Adipose tissue-
derived stem 
cells (ADSCs) 
Transdifferentiation 
into SCs via 
chemical induction 
on 2D tissue culture 
plates 
Acellular nerve grafts 
with differentiated 
cells showed 
superior sciatic nerve 
functional index, wet 
weight of 
gastrocnemius 
muscle, neural 
electrophysiology, 
Gao et 
al.
[193]
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and regenerated 
myelinated nerve 
fibers compared to 
other control groups, 
but statistically 
similar to 
autogenous nerve 
grafts. 
Acellular nerve graft ADSCs or 
BMSCs 
Transdifferentiation 
into SCs via 
chemical induction 
on 2D tissue culture 
plates 
Implantation of 
differentiated BMSC 
or ADSC via 
acellular nerve graft 
promoted sciatic 
nerve regeneration 
and functional 
recovery in rats, 
which was 
comparable to 
autografting with 
SCs. 
Wang et 
al.
[194]
 
3D collagen conduit Human dental 
pulp stem cells 
(hDPSCs) 
Transdifferentiation 
into SCs via 
chemical induction 
on 2D tissue culture 
plates 
Promoted and 
guided neurite 
outgrowth of DRGs 
in an aligned tissue-
engineered 3D 
collagen conduit in 
vitro. 
Martens et 
al.
[195]
 
Silicone tube with 
collagen gels 
ADSCs Transdifferentiation 
into SCs via 
chemical induction 
on 2D tissue culture 
plates 
In vivo results 
suggested that both 
differentiated and 
undifferentiated cells 
had potential to 
enhance axonal 
regeneration and 
myelination. 
Orbay et 
al.
[57]
 
Collagen nerve 
conduits 
BMSCs Transdifferentiation 
into SCs via 
chemical induction 
on 2D tissue culture 
plates 
Differentiated MSCs 
in collagen nerve 
conduits resulted in 
axonal regeneration 
equivalent to that of 
SCs but less 
effective than the 
nerve autograft. 
Ladak et 
al.
[18]
 
Microstructured 
collagen nerve guide 
(Perimaix) 
BMSCs Transdifferentiation 
into SCs via 
chemical induction 
on 2D tissue culture 
The pre-
differentiated BMSCs 
seeded in Perimaix 
nerve guide 
enhanced axonal 
Boecker et 
al.
[196]
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plates regeneration and 
myelination but did 
not significantly 
improve functional 
recovery.  
Commercial collagen 
conduits 
(NeuraGen® nerve 
guides) 
Schwann cells 
(SC), SC-like 
differentiated 
bone marrow-
derived 
mesenchymal 
stem cells 
(dMSC) or SC-
like 
differentiated 
adipose-derived 
stem cells 
(dASC) 
Transdifferentiation 
into SCs via 
chemical induction 
on 2D tissue culture 
plates 
Primary SCs showed 
significant 
improvement in distal 
stump sprouting. No 
difference in 
proximal 
regeneration. 
Conduits with dMSC 
and dASC showed 
diffuse sprouting 
pattern. Conduits 
with SCs showed 
enhanced cone 
pattern and a typical 
sprouting along the 
conduits walls.  
di Summa et 
al.
[197]
 
Genipin crosslinked 
gelatin annexed with 
tricalcium phosphate 
(TCP) ceramic 
particles 
ADSCs Transdifferentiation 
into SCs via 
chemical induction 
on 2D tissue culture 
plates 
Promoted 
proliferation and 
neuronal 
differentiation of 
ADSCs.  Conduits 
with differentiated 
ADSCs  showed 
morphology and 
distribution patterns 
of nerve fibers 
similar to the 
autografts. 
Liu et al.
[198]
 
Gelatin based 
matrigel implants 
ADSCs Transdifferentiation 
into SCs via 
chemical induction 
on 2D tissue culture 
plates 
Good neural 
differentiation of 
ADSCs with 
enhanced BDNF 
secretion. The 
transplanted cells via 
matrigel induced 
nerve fiber growth. 
Lopatina et 
al.
[44]
 
Fibrin nerve conduits Schwann cells 
(SC), SC-like 
differentiated 
bone marrow-
derived 
mesenchymal 
stem 
cells(dMSC) or 
Transdifferentiation 
into SCs via 
chemical induction 
on 2D tissue culture 
plates 
Fibrin conduit with 
SCs enhanced 
axonal regeneration 
compared to empty 
fibrin conduit. Both 
dASCs and dMSCs 
enhanced 
regeneration 
di summa et 
al.
[199]
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SC-like 
differentiated 
adipose-derived 
stem cells 
(dASC) 
distance. 
Fibrin glue scaffold 
and collagen 
tubulization 
Porcine skin-
derived 
mesenchymal 
stem cells 
(pSMSCs) 
Transdifferentiation 
into neurons via 
chemical induction 
on 2D tissue culture 
plates 
The neuron-like cell 
morphology and 
characteristic 
detected at 6h and 
24h of induction 
disappeared as at 48 
and 72 h. 
Transplanted cells 
showed remarkable 
in vivo nerve 
regeneration 
demonstrating 
histologically 
complete nerve 
bundles with highly 
detected  S-100 and 
p75 markers 
compared to non-cell 
grafted control fibers. 
Park et 
al.
[200]
 
Poly (lactic-
coglycolic acid) 
(PLGA, 85:15) 
Peripheral 
blood-derived 
mesenchymal 
stem cells 
(PBMSCs) 
Transdifferentiation 
into SCs via 
chemical induction 
on 2D tissue culture 
plates 
PLGA conduits with 
induced PBMSCs 
provided axonal 
regeneration and 
remyelination with 
expressing myelin 
specific markers and 
enhanced nerve 
conduction recovery, 
and restoration of 
motor function, and 
attenuated 
myoatrophy and 
neuromuscular 
junction 
degeneration in the 
target muscle. 
Pan et al.
[201]
 
Thin poly (e-
caprolactone) and 
poly (D,L-lactic acid) 
based, hydrophobic 
film scaffolds 
ADSCs Transdifferentiation 
into SCs via 
chemical induction 
on 2D tissue culture 
plates 
Differentiated ADSC 
expressed S100 and 
GFAP markers with 
high attachment and 
proliferation rate on 
the films. They 
showed functional 
activity by triggering 
Tse et al.
[202]
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neurite outgrowth of 
dorsal root ganglia 
neurons. 
Poly-3-
hydroxybutyrate 
(PHB) strips with 
fibrin glue matrix 
ADSCs Transdifferentiation 
into SCs via 
chemical induction 
on 2D tissue culture 
plates 
PHB strips seeded 
with SCs or 
transdifferentiated 
ADSCs showed 
significantly better 
functional ability than 
the control groups. 
Schaakxs et 
al.
[203]
 
Poly(DL-lactide-e-
caprolactone) (PLC) 
based commercial 
membranes 
(Vivosorbs) 
Human 
umbilicalcord 
matrix MSCs 
(HMSCs) 
Neuroglial-like 
differentiation via 
chemical induction 
on 2D tissue culture 
plates 
The animals in vivo 
transplanted with 
either 
undifferentiated or 
differentiated 
HMSCs showed 
enhanced recovery 
of motor and sensory 
function 
accompanied by an 
increase in myelin 
sheath. 
Gaertner et 
al.
[204]
 
Conduit composed 
of copolymer of 75% 
L-lactic acid and 
25% e-caprolactone 
filled with 
atelocollagen (70 
wt.% type I and 30 
wt.% type III 
collagen) 
Monkey MSCs Transdifferentiation 
into SCs via 
chemical induction 
on 2D tissue culture 
plates 
Auto-cell 
transplantation 
therapy using 
transdifferentiated 
MSCs accelerated 
axonal regeneration 
and functional 
recovery in injured 
nerves. 
Wakao et 
al.
[205]
 
PLA nerve conduits ASCs or 
DPSCs 
Transdifferentiation 
into SCs via co-
culturing SCs with 
adipose-derived 
adult stem cells 
(ASCs) or dental 
pulp stem cells 
(DPSCs) 
Synergistic effect of 
cells provided 
enhanced secretion 
of neurotrophic 
factors in vitro. The 
in vivo studies 
indicated that PLA 
conduits with co-
cultured SCs and 
ASCs provided 
improved functional 
recovery. 
Dai et al.
[206]
 
Silk fibroin 
(SF)/collagen based 
tissue-engineered 
nerve conduit 
ADSCs Transdifferentiation 
into SCs via co-
culturing SCs with 
ADSCs 
The transplanted 
conduits provided 
accelerated nerve 
regeneration in 1-cm 
long sciatic nerve 
Xu et al.
[207]
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defects in rats. 
 
 
 
 
 
 
 
 
 
 
 
 
Acellular muscle grafts, mimicking the natural nerve structure and elementary nerve ECM, 
can be obtained from muscles by using chemical extraction procedures. Following 
transdifferentiation into SCs via regularly used chemical procedures, the transplanted SC-
like cells via acellular grafts provided improved PN regeneration. [17, 191] Similarly, acellular 
nerve grafts obtained from sciatic nerves, were used for stem cell transplantation of different 
sources (BMSCs or ADSCs) upon transdifferentiation.[193, 194] The acellular grafts with 
differentiated cells promoted sciatic nerve regeneration, myelination and functional recovery 
including sciatic nerve functional index (SFI), wet weight of gastrocnemius muscle, neural 
electrophysiology (NEP), superior to other control groups, but statistically similar to 
autogenous nerve grafts. In a different study, Lin et al.[192] obtained neurons and SCs 
through differentiation of Sprague Dawley (SD) rat hair follicle neural crest stem cells with 
sonic hedgehog/retinoic acid and neuregulin1, respectively. Then, they used acellular nerve 
xenografts seeded with both neurons and SCs to bridge long-distance gaps in rat sciatic 
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nerves. They reported that the synergetic effect enhanced regeneration of axons and long-
term cell survival upon transplantation.  
Biopolymers (Collagen/Gelatin/Chitosan/Fibrin) are considered promising substitutes of 
autologous nerve grafts. Tissue-engineered 3D collagen conduits or collagen gels/scaffolds 
filling tubes made of different materials (i.e. silicone) were used with SC-like differentiated 
stem cells of various sources (human dental pulp stem cells (hDPSCs), BMSCs and ADSCs) 
in order to facilitate PN regeneration.[18, 57, 195] In general, stem cells transdifferentiated to SC-
like cells in collagen nerve conduits showed a greater or equivalent axonal regeneration to 
that of obtained by undifferentiated stem cells or SCs; however, the nerve autograft still 
remains the most effective conduit for supporting nerve regeneration.[18, 57] Collagen also 
serves as the base material of commercially available conduits such as microstructured 
collagen nerve guide (Perimaix) or collagen based NeuraGen® nerve guides. The SC-like 
differentiated MSCs or ADSCs were used with Perimaix and NeuraGen® nerve conduits in 
recent studies and showed high affinity of regenerative cells accompanied with promising 
axonal regeneration and myelination; however, did not enable significant functional recovery 
and further modifications were suggested for future tissue-engineering applications (Figure 
5).[196, 197]  
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Figure 5. (A) Expression of SC markers in diffMSCs and MSCs. At 3 weeks after cultivation 
in differentiation medium, diffMSCs expressed the typical SC markers to a similar extent as 
normal SCs. The marker human epidermal growth factor receptor 2 (erbB2) was less 
expressed, but still higher than the non-differentiated cells. (B) Regenerated sciatic nerves at 
12 weeks after implantation. No macroscopic signs of inflammation, hematoma or extensive 
scar tissue formations were observed. (C) Quantification of 1,1ʹ-dioctadecyl-3,3,3ʹ,3ʹ-
tetramethylindocarbocyanine perchlorate (DiI) traced sensory and motor neurons at 12 
weeks after transplantation. Quantification of positively labelled somatosensory neurons 
demonstrated similar numbers of regenerated sensory fibres between all experimental 
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groups. Quantification of the lumbar spinal cord for positively labelled motor neurons 
revealed a similar pattern as for the sensory fibres; no significant differences in motor neuron 
counts could be detected between the experimental groups. The functional recovery never 
reached pre-operative values, but demonstrated enhancement with respect to controls. 
Reproduced with permission.[196] Copyright 2016, John Wiley & Sons.  
 
Another important biopolymer, gelatin, a derivative of collagen, is also widely used to 
produce conduits. A biodegradable nerve conduit containing genipin crosslinked gelatin 
annexed with tricalcium phosphate (TCP) ceramic particles was used with neuron-like 
differentiated ADSCs[198] while gelatin based matrigel implants[44] were used with ADSCs 
differentiated into neural lineages. Both studies demonstrated that gelatin based conduits 
promote cell proliferation and differentiation and enhance nerve fiber growth. 
Other biomaterials, such as chitosan and fibrin, are also used to produce conduits. 
For instance, Li et al.[208] investigated the effect of silanization on porous chitosan conduits in 
terms of cellular properties and differentiation. Fibrin nerve conduits seeded with various cell 
types (primary Schwann cells and adult stem cells differentiated to a Schwann cell-like 
phenotype) were also tested for repair of sciatic nerve injury revealing enhanced 
regeneration potential of differentiated ADSCs in fibrin conduits.[199] The combined use of 
different biomaterials for conduit production was also demonstrated. Park et al.[200] used 
fibrin glue scaffolds and collagen tubulization with neuron-like cell differentiated porcine skin-
derived mesenchymal stem cells (pSMSCs). Although the neuron-like characteristics 
disappeared as the induction time extended to 48 and 72 h, the transplanted cells showed 
remarkable in vivo nerve regeneration with high immunolabelling for S-100 protein and 
p75NTR in regenerated nerve fibers indicating SC-like differentiation.  
Synthetic Polymers (PLLA/PLGA/PCL/PHB) have also been proposed for alternative 
artificial nerve conduits. Pan et al.[201] prepared a conduit with poly (lactic-coglycolic acid) 
(PLGA, 85:15) and used peripheral blood-derived mesenchymal stem cells (PBMSCs) that 
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were induced into SC-like cells for transplantation into crushed rat sciatic nerves. The results 
indicated that the induced PBMSCs transplanted in PLGA conduits wrapped the injured 
axons and provided enhanced axonal regeneration and remyelination by expressing myelin 
specific markers along with the restoration of nerve conduction and motor function. The 
attenuated myoatrophy and neuromuscular junction degeneration in the target muscle was 
also observed.  
The use of synthetic polymer based conduits make further modifications possible. 
For instance, the surface of the aligned and aminolyzed poly-Llactide (PLLA) nanofibrous 
scaffolds were modified with graphene oxide (GO) nanosheets providing rough and 
hydrophilic surface microstructure that enabled and promoted aligned SCs proliferation, 
which can potentially be used for stem cell differentiation.[209] On the other hand, the use of 
fibers and strips is also another approach to provide guided growth as well as supporting the 
differentiation. Polyhydroxybutyrate (PHB) fibers of a fixed weight threaded through the 
lumen of a PHB conduit [210] or PHB strips filled with a fibrin glue matrix containing SC-like 
differentiated adipose-derived stem cells (dASCs) [203] are good examples. These studies 
suggested that the differentiated cells kept their functionality during the transplantation while 
the transplanted undifferentiated MSCs showed in vivo differentiation into SCs showing 
significant functional ability (Figure 6).[203, 210]  
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Figure 6. Nerve histology 3 months after surgical implantation of PHB strips. Nerve sections 
taken from proximal and distal sections (A) low (B) high magnification. (C) Total number of 
axons/nerve. (D) Percent myelinated area/nerve. Morphologically healthy proximal nerves 
with clear fascicular structures were observed in all groups while the dASC- and SC-treated 
animals had many regenerated axons in their distal stumps. Significantly higher total 
numbers of myelinated axons and myelin percentage were observed for both cell type 
treatment groups in the distal stumps. Reproduced with permission.[203] Copyright 2017, 
John Wiley & Sons.  
 
Some of these polymers were used in combination to develop conduits and further 
commercialized to be used in peripheral nerve injuries. Poly (e-caprolactone) and poly (D,L-
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lactic acid) based conduits were produced via solvent casting method to create thin, 
hydrophobic film scaffolds, which can support the differentiation of ADSCs into a Schwann 
cell-like phenotype and cell transplantation.[202] Another study used Poly(DL-lactide-e-
caprolactone) (PLC) based commercial membranes (Vivosorbs) to evaluate the therapeutic 
value of undifferentiated human umbilical cord matrix MSCs (HMSCs) or neuroglial-like 
differentiated HMSCs on rat sciatic nerve after axonotmesis injury providing enhanced 
recovery of motor and sensory function.[204] This study indicated that HMSCs differentiated 
into neuroglial-like cells, consumed significantly less glucose and produced significantly less 
lactate compared to native HMSCs that undergo expansion. Based on this observation, they 
hypothesized that during HMSC differentiation in neuroglial-like cells, the glycolytic process 
is switched to oxidative metabolism, which could be triggered by several mechanisms, 
including inhibition of oxidative phosphorylation, dysfunctional Krebs cycle, or inactivation of 
p53, contribute to the cellular expansion and differentiation. In some cases, synthetic 
polymers were used in combination with natural biopolymers in order to enhance the 
regeneration capacity. In one study, a conduit, composed of copolymer of 75% L-lactic acid 
and 25% e-caprolactone filled with atelocollagen (70 wt.% type I and 30 wt.% type III 
collagen), was used with SC-like differentiated monkey MSCs in order to observe the 
regeneration performance for 1 year.[205] 
Alternatively, the stem cells, differentiated via in vitro co-culture approach, can further 
be combined with NGCs of synthetic or biopolymers and transplanted into animals to 
enhance nerve regeneration. Based on this, some studies used adipose-derived adult stem 
cells (ASCs) or dental pulp stem cells (DPSCs) co-cultured with SCs in PLA conduits or silk 
fibroin (SF)/collagen based tissue-engineered nerve conduits to treat sciatic nerve defects in 
rats.[206, 207] This approach provided enhanced nerve regeneration and functional recovery 
through the synergistic effect of cells providing enhanced secretion of neurotrophic factors.   
 
Scaffolds Materials 
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In most studies, stem cells were first transdifferentiated in vitro into desired cell lineages on 
two-dimensional (2D) tissue culture plates and then these cells seeded in nerve guidance 
conduits (NGCs) made from different materials and possessing different physical cues and 
implanted into the animals. On the other hand, the in vitro differentiation of stem cells directly 
in the NGCs before the transplantation is another strategy saving time and effort (Table 5).  
 
 
 
 
Table 5. Summary of transdifferentiation directly on conduits/scaffolds using chemical 
stimuli, conditioned media or co-culture approach followed by transplantation. 
Conduit/Scaffold 
Type 
Stem Cell 
Source 
Differentiation 
Method 
Outcome Reference 
Gelatin-based 3D 
conduits with three 
different 
microstructural 
(nanofibrous, 
macroporous and 
ladder-like) 
Bone marrow-
derived  
mesenchymal 
stem cells 
(BMSCs) 
Transdifferentiation 
into SCs via 
chemical induction 
within conduit 
microstructure 
3D ladder-like 
conduit structure 
with complex 
modulus of 
0.4x106 Pa and 
pore size of 150 
µm provided the 
most favorable 
microenvironment 
for MSC 
transdifferentiation 
leading to 85% 
immunolabeling of 
all SC markers 
and enhanced 
paracrine activity 
as well as MSC 
attachment, 
proliferation and 
spreading, 
creating 
interconnected 
cellular networks 
with large numbers 
of viable cells. 
Uz et al.
[122]
 
PLLA based 
conduits with 
different 
Neural stem cells 
(NSCs) 
Transdifferentiation 
into neurons via 
chemical induction 
The nanofibrous 
structure with 
higher surface 
Zeng et 
al.
[211]
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microstructures 
(nanofibrous, 
microporous and 
ladder-like) and 
microchannels 
on conduits area and lower 
mechanical 
strength, resulting 
from relatively high 
crystallinity and 
brittle 
characteristics, 
induced the 
neuronal 
differentiation of 
NSCs compared to 
other structures. 
Polycaprolactone 
(PCL) electrospun 
fibers 
BMSCs Transdifferentiation 
into SCs via 
chemical induction 
on conduits 
Alignment, 
diameter, and 
surface properties 
of the PCL 
electrospun fibers 
promoted the 
differentiation of 
BMSCs into SCs, 
the secretion of 
neurotrophins and 
dictated the 
morphology and 
alignment of the 
derived cells. 
Xue et 
al.
[123]
 
Micropatterned PLA 
and PS films 
BMSCs Transdifferentiation 
into SCs via 
chemical induction 
on conduits 
Presence of 
patterns and type 
of polymers did not 
influence the 
degree of 
differentiation 
while the patterns 
significantly 
affected the 
alignment and 
elongation of 
differentiated 
MSCs. 
Sharma et 
al.
[19]
 
PHVB and PEO 
based electrospun 
3D oriented 
nanofiber scaffolds 
Adipose tissue-
derived stem cells 
(ADSCs) 
Neuronal 
transdifferentiation 
through the 
temporally 
sequential use of 
miR-218 and 
Fibroblast Growth 
Factor 2 
Demonstrated the 
neuronal 
differentiation of 
ADSCs. 
Hu et al.
[25]
 
Photopolymerizable 
PLL-grafted PEGDA 
Neural progenitor Differentiation of 
NPC into mature 
Hydrogels with 2% 
PLA grafting also 
Cai et 
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hydrogels cell (NPC) neurons via 
chemical induction 
on conduits 
supported 
differentiation of 
NPC into mature 
neurons with 
extensive neurite 
formation and 
astrocytes rather 
than 
oligodendrocytes. 
However, the 
hydrogels with 0% 
and 5% of PLLA 
grafting did not 
significantly 
supported NPC 
differentiation. 
al.
[212]
 
Electrospun Poly(L-
lysine) modified zein 
(ZPLL) nanofibrous 
membranes with 
different PLL 
contents 
NSCs Differentiation of 
NSCs into mature 
neurons via 
chemical induction 
on conduits 
At PLL content of 
3.57%, cell 
adhesion and 
proliferation 
proved to be the 
best and most 
differentiated 
toward mature 
neurons with 
extensive neurite 
formation and 
astrocytes rather 
than 
oligodendrocytes. 
Miao et 
al.
[27]
 
Neurotrophin-3 (NT-
3) loaded poly-(lactic 
acid-co-glycolic acid) 
(PLGA) conduits 
Co-seeded NSCs 
and Schwann 
cells (SCs) 
Differentiation of 
NSCs into neurons 
via co-culturing with 
SCs on conduits 
Sustained NT-3 
release and co-
culturing with SCs 
triggered the 
neuronal 
differentiation of 
NSCs along with 
the formation of 
synaptic structures 
and myelin 
sheaths. 
Xiong et 
al.
[213]
 
Layer of reduced 
graphene oxide 
(rGO) nanosheets on 
the surface of 
bioactive three-
dimensional (3D) 
porcine acellular 
dermal matrix 
BMSCs Neuronal 
differentiation via 
neuronal culture 
medium on conduits 
rGO-assembled 
PADM scaffold 
promoted MSCs to  
neuronal cells 
differentiation with 
higher protein and 
gene expression 
levels. 
Guo et 
al.
[96]
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(PADM) channels 
Multiwall CNTs 
(MWNTs) and 
polydimethylsiloxane 
(PDMS) based 
composite sheets 
ADSCs Differentiation into 
SCs using a mixture 
of glial growth 
factors on conduits 
Differentiated 
ADSCs co-
cultured with 
DRGs enhanced 
neurite outgrowth. 
Han et 
al.
[214]
 
Polydimethylsiloxane 
(PDMS) scaffold 
Stem cells 
obtained from 
human exfoliated 
deciduous teeth 
(SHEDs) 
Differentiation 
potential of stem 
cells obtained from 
human exfoliated 
deciduous teeth 
(SHEDs) into a rat 
Schwann cell (RSC) 
on a 
polydimethylsiloxane 
(PDMS) scaffold in 
static and dynamic 
culture in vitro. 
Both static and 
dynamic cultures 
supported the 
differentiation, 
whereas the 
dynamic culture 
resulted in 
formation of 
neurospheres in 
higher amounts 
within significantly 
shorter times, 
which could be 
further 
differentiated into 
neurons and 
neuroglial cells 
upon culturing in 
RSCs medium. 
Su et al.
[215]
 
3D chitosan conduit SHEDs Differentiation 
potential of stem 
cells obtained from 
human exfoliated 
deciduous teeth 
(SHEDs) into a rat 
Schwann cell (RSC) 
on a 
polydimethylsiloxane 
(PDMS) scaffold in 
static and dynamic 
culture in vitro 
Dynamic culture 
system generated 
fluid shear stress 
and enhanced 
nutrient transfer, 
promoting the 
differentiation of 
SHEDs to neural 
cells by expressing 
the neural stem 
cell marker. 
Su et al.
[216]
 
Chitosan fibers Neuroepithelial 
stem cells (NEPs) 
Differentiation of 
NEPs into neurons 
and glia via chemical 
induction on 
conduits 
NEPs could firmly 
attach and grow 
on the chitosan 
fibers enabling 
differentiation of 
NEPs into neurons 
and glia. 
Fang et 
al.
[217]
 
Fibrin matrix Ectomesenchymal 
stem cells 
(EMSCs) 
harvested from 
Differentiation into 
SCs via chemical 
induction on 
Fibrin matrix 
enhanced the 
EMSCs 
proliferation, 
Chen et 
al.
[218]
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the nasal 
respiratory 
mucosa 
conduits expression of 
myelination-related 
molecules, 
synthesis of 
neurotrophins and 
differentiation into 
SC-like phenotype 
compared to 
fibronectin based 
matrix and 2D 
tissue culture 
plates. 
Hyaluronan based 
membranes and 
fibrin-glue meshes 
Neurospheres 
isolated from skin 
and adipose 
tissues 
Differentiate in 
glial/neuron-like cells 
on hyaluronan 
based membranes 
and fibrin-glue 
meshes via chemical 
induction  
Neurospheres 
isolated from skin 
and adipose 
tissues were able 
to differentiate in 
glial/neuron-like 
cells on 
hyaluronan based 
membranes and 
fibrin-glue meshes 
upon induction 
without any 
chromosomal 
imbalance. 
Gardin et 
al.
[219]
 
 
 
 
The conduit properties such as structure, composition and elasticity can influence stem cell 
differentiation [77, 106, 107, 109, 220] [72, 78, 110-115].  The dimension in which cells are cultured is also 
a crucial factor in determining the differentiation properties of the cells. The current 
understanding of most biological mechanisms, including differentiation, has been garnered 
from cells cultured on 2D surfaces. Most studies examining MSC transdifferentiation have 
relied on 2D tissue culture plates[15, 17, 20, 21]; however, the cells naturally exist in a complex 
three-dimensional (3D) microenvironment composed of various ECM molecules, mixed cell 
populations and cell-secreted factors. Therefore, employing a 3D culture model is more 
relevant to the physiological condition to explore cell-to-cell and cell-to-matrix interactions 
related to cellular transdifferentiation.  However,  the current knowledge with respect to the 
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influences of mechanical and structural properties of 3D scaffolds on the transdifferentiation 
behavior of MSCs is significantly limited.[116] 
Recent studies have demonstrated that matrix stiffness has a significant influence on 
the transdifferentiation of MSCs determining not only the differentiating cell lineage but also 
the triggered signaling pathways. The MSCs cultured on 2D substrates with elastic moduli of 
lower (0.1–1 kPa), intermediate (8–17 kPa) or higher ranges (34 kPa) showed 
transdifferentiation tendency into neural, myogenic or osteogenic phenotypes, respectively. 
Based on this, it was previously reported that the highest expression of neural (ENO2), 
myogenic (MYOG) and osteogenic (Runx2, OC) transcription factors secreted from MSCs 
cultured on polyethylene glycol-silica (PEG-silica) based nanocomposite 3D gels were 
obtained for gels with matrix stiffness of 7, 25 and 75 Pa, respectively. [221] Along with the 
mechanical properties of conduits, their microstructural properties also influence 
differentiation of stem cells. In a recent study, gelatin-based 3D conduits with ladder-like 
structure possessing complex modulus of 0.4x106 Pa and pore size of 150 µm provided the 
most favorable microenvironment (compared to macroporous and nanofibrous structures) for 
MSC transdifferentiation leading to 85% immunolabeling of all SC markers and enhanced 
paracrine activity as well as MSC attachment, proliferation and spreading, creating 
interconnected cellular networks with large numbers of viable cells (Figure 7). [122] This study 
anticipated that differentiation of MSCs was modulated by blocking of the BMP/Smad 
signaling pathway, which promotes integrin internalization, enhancing bone morphogenetic 
protein receptors (BMPR) endocytosis and neuronal gene expression. 
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Figure 7. Transdifferentiation of MSCs into SCs within 3D conduits, ladder-like (LL), 
macroporous (MP) and nanofibrous (NF), and on 2D tissue culture polystyrene (TCPS) 
plates. (A) Immunocytochemical analysis. (B) Neurotrophic factor secretion. Reproduced 
with permission.[122] Copyright 2017, Elsevier.  
 
In addition to the mechanical and microstructural properties, it is also important to use the 
combination of aligned matrix and optimized differentiation medium properties, which in turn 
reveals the synergetic influence of extrinsic matrix signaling with intrinsic cell programming 
for successful differentiation. In a similar study, PLLA based conduits with nanofibrous 
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structure and microchannels along with higher surface area and lower mechanical strength 
induced neuronal differentiation of NSCs compared to microporous and ladder-like 
structures. [211] 
In addition to the microchannels, longitudinal fibers or surface micropatterns have 
also been used to provide guided axonal growth and stem cell differentiation. It was reported 
that changing the alignment, diameter, and surface properties of electrospun PCL 
microfibers promoted the differentiation of stem cells into Schwann cells or neurons, the 
secretion of neurotrophins and dictated the morphology and alignment of the derived 
cells.[123, 222] These studies showed that the electrospun fibers support stem cell 
differentiation and alignment. They further demonstrated that fiber-induced cell alignment 
can effectively activate canonical Wnt signaling in adult NSCs, and further enhance the 
differentiation induced by biochemical cues mainly by influencing the dynamics of 
intracellular β-catenin bioavailability. However, in a recent study, it was also reported that the 
presence of micropatterns or type of polymer films (made from PLA or PS) did not enhance 
the degree of MSCs transdifferentiation into SCs while significantly affecting the alignment 
and elongation of differentiated MSCs.[19] 
The formulation and composition of the conduit material also determines the 
performance of the developed conduits and degree of differentiation. Recently, Hu et al.[25] 
demonstrated neuronal differentiation of adipose-derived mesenchymal stem cells (ASCs) 
through the temporally sequential use of miR-218 and FGF2 directly on PHVB and PEO 
based electrospun 3D oriented nanofiber scaffolds. In similar studies with different conduit 
formulations, it was observed that the change of PLL content had a significant influence on 
cellular properties, such as adhesion, proliferation and differentiation. Photopolymerizable 
PLL-grafted PEGDA hydrogels with 2% PLL grafting density[23] and electrospun poly(L-
lysine) modified zein (ZPLL) nanofibrous membranes with 3.57% PLL content [27] were 
reported to increase viability, attachment, proliferation, and further support differentiation of 
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neural progenitor cell (NPC) and neural stem cells (NSCs) into mature neurons with 
extensive neurite formation, respectively.   
The sustained release property and surface modification of the developed conduits 
was also used to induce the differentiation of stem cells. In the work of Xiong et al.[213] the 
sustained NT-3 release from poly-(lactic acid-co-glycolic acid) (PLGA) conduits triggered 
neuronal differentiation of NSCs along with the formation of synaptic structures and myelin 
sheaths when co-seeded with Schwann cells (SCs). The surface modification of conduits 
with carbon based conductive materials (i.e. reduced graphene oxide (rGO) or multiwall 
CNTs (MWNTs)) is a recent strategy to support stem cell differentiation.[96, 100, 214] It was 
shown that 3D porcine acellular dermal matrix (PADM) channels modified with assembled 
layers of rGO nanosheets promoted the differentiation of MSCs into neuronal cells in the 
presence of neuronal culture medium.[96]  In another study, MWNTs and 
polydimethylsiloxane (PDMS) based composite sheets with superior mechanical strength 
and electroconductivity supported the differentiation of ASCs into SCs in a mixture of glial 
growth factors.[214]  
Numerous studies using different conduit/scaffolds made from various materials 
(chitosan fibers, fibrin matrix, hyaluronan-based membranes and fibrin-glue meshes) have 
been used to differentiate specific stem cell types (ectomesenchymal stem cells (EMSCs) 
harvested from the nasal respiratory mucosa, neuroepithelial stem cells (NEPs), 
neurospheres generated from skin and adipose tissues) into glial/neuron-like cells upon 
chemical stimuli.[217-219] Among these cell types, stem cells from human exfoliated deciduous 
teeth (SHEDs), an alternative source of adult stem cells, were shown to exhibit a spindle 
fibroblastic morphology in static culture while they aggregated into neurosphere-like clusters 
under a dynamic culture.[215, 216] It was shown that both static and dynamic cultures 
supported the differentiation of SHEDs into a rat Schwann cell (RSC), whereas the dynamic 
culture resulted in formation of neurospheres in higher amounts within significantly shorter 
times, which could be further differentiated into neurons and neuroglial cells upon culturing in 
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RSCs medium. The further use of dynamic culture systems with 3D chitosan conduits 
generated fluid shear stresses and enhanced nutrient transfer, promoting the differentiation 
of SHEDs to neural cells.[216] 
 
6. Stem Cell Differentiation via Electrical or Electrical/ Chemical Stimuli 
Electrical fields within the ECM have been known for centuries, but their exact nature in 
terms of time-dependent voltage gradients and its role in developmental processes of 
human/living organisms have only recently been investigated.[150, 223, 224] These electrical 
gradients are being related to the spatial variations in ion pumps or leakage across individual 
cells or across layers of cells. Stem cell differentiation has conventionally been conducted 
via chemical stimuli, however numerous reports have demonstrated that electrical stimuli 
have augmented or in some cases circumvented chemical stimuli (Table 6).[90-93, 95]   
 
 
Table 6. Summary of transdifferentiation using electrical stimuli either alone or in 
combination with chemical induction. 
Conduit/Scaffold 
Type 
Stem Cell 
Source 
Differentiation 
Method 
Outcome Reference 
2D tissue culture plates Bone 
marrow-
derived  
mesenchymal 
stem cells 
(BMSCs) 
Combined 
chemical and 
electrical stimuli 
based 
differentiation 
Electrical stimuli 
significantly 
decreased 
proliferation rate, 
but 
increased 
neuronal 
differentiation. 
Kim et al.
[90]
 
2D tissue culture plates Human 
mesenchymal 
stromal cells 
(hMSCs) 
Combined 
chemical and 
electrical stimuli 
based 
differentiation 
Electrical stimuli 
enhanced hMSCs 
into SCs 
transdifferentiation  
and enhanced the 
Schwann cell-like 
functional 
behavior and 
functional activity 
via the induction 
Kim et 
al.
[225]
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of neurotrophic 
factor release and 
guided axonal 
outgrowth in vivo. 
Poly(3,4-
ethylenedioxythiophene) 
(PEDOT)− 
reduced graphene oxide 
(rGO) hybrid microfiber  
scaffold 
BMSCs Combined 
chemical and 
electrical stimuli 
based 
differentiation 
Enhanced 
proliferation and 
neural 
Differentiation. 
Guo et 
al.
[100]
 
Graphene-based 
substrate 
Bone 
marrow-
derived 
human 
mesenchymal 
stem cells 
(hMSCs) 
Combined 
chemical and 
electrical stimuli 
based 
differentiation 
Graphene-based 
substrates 
support neuronal 
differentiation of 
stem cells up-
regulating cell 
through 
intracellular 
calcium influx and 
activated focal 
adhesion kinase 
signaling pathway. 
Lee et al.
[91]
 
Flexible, inkjet-printed 
graphene interdigitated 
electrode (IDE) circuit 
BMSCs Sole electrical 
stimuli 
Differentiation of  
MSCs into SCs 
via electrical 
stimuli on 
graphene based 
substrates was as 
effective as 
conventionally 
used chemical 
stimuli. 
Das and Uz 
et al. 
[95]
  
Graphene oxide (GO) 
nanosheets modified 
aligned and aminolyzed 
poly-Llactide (PLLA) 
nanofibrous scaffolds   
Schwann 
cells 
No 
differentiation 
Enabled aligned 
and promoted 
SCs proliferation 
and can 
potentially be 
used for stem cell 
differentiation. 
Zhang et 
al.
[209]
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For example, differentiation of MSCs to SCs via chemical induction methods using specific 
compositions of culture media (using expensive growth factors) is well studied, including our 
own previous work.[16, 17, 122, 226] However, the effect of electrical stimuli either alone or in 
combination with chemical induction on the differentiation of adult stem cells of different 
sources into SCs or neurons have recently been investigated.[90-95, 100, 227]  The link between 
electrical stimuli and stem cell differentiation has been at least loosely attributed to the 
regulation of various signaling pathways such as, FAK and p38 [91, 96-100], ion channels and 
ERK pathway[102-104], MAPK, PI3K, and ROCK,[92, 101] and ROS.[92, 105] Several theories such 
as differentiation via cell adhesion[228], cell proliferation[229], cell migration[230], and protein 
generation[231] have been proposed to help explain the connection between electrical stimuli 
and cellular differentiation. One study (Kim et al.[90]) indicated that intracellular Ca2+ signaling 
that is induced by ELF-EMF is a novel regulatory mechanism that controls neural 
differentiation of BM-MSCs. They also hypothesized that the signaling pathways related to 
ferritin has potential influence on neural differentiation. However, further investigation needs 
to be performed to elucidate the physicochemical underpinnings behind this connection.  
Nevertheless, there are recent studies investigating the effect of electrical stimuli parameters 
(such as, voltage, frequency, electrical field strength and so on) along with potential 
conductive material based conduits/scaffolds targeting the stem cell differentiation and 
peripheral nerve regeneration. The following section reviews the recent progress made in 
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stem cell differentiation and neural cell growth via solely electrical or electrical assisted 
stimulation. 
Numerous scaffold materials including those comprised of conductive polymers (e.g., 
PANI, PEDOT) as well as carbon nanomaterials and even silk have been used to directly 
stimulate cells for neural regeneration purposes.  For example, electrical stimulation via 
polyaniline-based nerve growth conduits has demonstrated increased cellular growth and 
proliferation than unstimulated cells.  Protonated PANI conduits used to produce an 
electrical field of 10 mV/cm – 2 V/cm was able to alter the cytoskeletal arrangement of 
hMSCs to produce long filopodial extensions and eventually neural-like cells.[232]  A blended 
PLLA/PANI scaffold was used to electrically stimulate rat nerve cells which resulted in 
processes with lengths of 24 ± 4 μm compared to 15 ± 3 μm without electrical stimulation. [233]  
As mentioned previously, graphene-PEDOT hybrid microfibers and inkjet printed graphene 
micro/nanostructured via a rapid pulse laser technique has been used to differentiate MSCs 
into neural-like and Schwann-like phenotypes respectively.[95, 100]  The former using chemical 
fibroblast growth factors along with electrical stimuli to induce MSC differentiation and the 
latter using electrical stimuli only (Figure 8).  
 
Figure 8. Transdifferentiation of MSCs into SCs on graphene substrates via electrical 
stimuli. SC-like MSCs were obtained by applying chemical free electrical stimuli of 100 mV at 
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50 Hz during 10 min for 15 days on laser annealed interdigitated graphene circuits. 
Reproduced with permission.[95] Copyright 2017, Wiley.  
 
Patterned electronic silk films (derived from Bombyx mori silkworm) were capable of 
enhancing axon outgrowth and alignment via electrical stimulation (120 mV, 1 kHz, for 45 
min daily) and  surface patterning (grooves with dimensions 3.5 µm width and 500 nm depth) 
over silk patterns that did not include electrical stimulation or patterning. [234] Other research 
groups have explored the effects of long-term (i.e., 4 weeks) electrical stimulation in the form 
of biphasic electric current (BEC) to stimulate axonal regeneration by differentiating hMSCs 
to into Schwann cells.[235] The BEC stimulation increased the functional activity of Schwann 
cell and significantly increased axonal outgrowth.  Moreover, the concomitance of Schwann 
cell implants with electrical stimulation (+ 50 mV mm−1dc) has demonstrated a 3.2-fold 
increase in neurite outgrowth over unstimulated control neurons. [236] Others have 
demonstrated that ‘electro-acupuncture’ (i.e., electrical stimulation) at spinal cord injury sites 
alone, and more significantly with the implantation of MSCs, further lead to partial functional 
recovery after a spinal cord injury.[94]  It is also important to note that such electrical fields 
have shown to align the migration of neuronal stem/progenitor cells to the cathode and 
hence neuronal cell regrowth could effectively be directed towards the injury site. [223] 
Other researchers have used various indirect or non-contact methods to stimulate 
stem cell differentiation and/or neural cell growth.  For example, graphene-PET mixed 
materials have been used to stimulate neural cells via non-contact electrical field 
stimulation.[237] Results demonstrate that this applied electrical field promoted new cell-to-cell 
coupling and strengthened existing cell-to-cell coupling which could facilitate the joining and 
growth of implanted neural cells to existing cells at a nerve damage cite. Likewise, other 
research groups have used now direct means to stimulate neural cell regrowth via low 
intensity pulsed ultrasound (LIPUS).[238, 239] These reports demonstrate that LIPUS might 
prompt a faster regeneration of the autografting sciatic nerve in the rat model. Others have 
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demonstrated that extremely low-frequency electromagnetic fields (ELF-EMF) can induce 
neural differentiation in bone marrow derived MSCs by significantly decreasing the rate of 
proliferation, which subsequently increases neuronal differentiation. [90]  Others have shown 
that ELF-EMF synergistically increased biological efficacy of neuronal differentiation in bone 
marrow-derived hMSCs grown on graphene-coated substrates.[91, 92]  
These studies showed that neuronal differentiation is achieved by altering global 
gene expression profile via ELF-EMF, which up-regulates cell adhesion through intracellular 
calcium influx and integrin mediated focal adhesion kinase signaling pathway that is 
stimulated by extracellular matrix production. The up-regulation of calcium signaling and 
phosphorylation of cAMP response element binding (CREB) pathway enhance the neuronal 
differentiation.[91]  
 
 
 
 
7. Conclusion and Future Perspective 
The application of cell-based nerve regeneration therapies has been a promising strategy for 
the treatment of large PN injuries including for several clinical studies as summarized 
previously. The transdifferentiation of adult stem cells into SC or NC-like phenotypes via 
chemical, electrical or synergetic co-culture stimuli or their various combinations that have 
recently been explored for PN regeneration, have considerable translational potential for 
cell-based nerve regeneration therapies using nerve guidance conduits with desired features 
and autologous transplantation. The chemical stimuli based transdifferentiation strategies 
involves the use of expensive chemicals and growth factors while the synergetic co-culture 
of different cells (mostly SCs with stem cells) for transdifferentiation that suffers from lack of 
cell availability and slow in vitro growth. Both of the strategies have difficulties in controlling 
the final fate of the implanted, transdifferentiated cell population since most often the 
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transdifferentiated cells show tendency to revert back to their original state when the 
transdifferentiation conditions are removed. Besides these strategies, to date no research 
has elucidated the strength and duration of the applied electrical field to control the stem cell 
transdifferentiation process.   
A few reports have suggested strategies for transdifferentation of stem cells using 
combined chemical and electrical stimuli and a very recent study demonstrated the potential 
of sole electrical stimuli in transdifferentiating the stem cells. Such use of electrical stimuli 
along with ideal conduit structures may be a promising approach to enable 
transdifferentiation but also serve to regulate stem cell fate commitment and peripheral 
nerve regeneration. In addition, the strategy of using electrical stimuli via nerve guidance 
conduits has also potential to provide direct in vivo and in situ transdifferentiation and nerve 
regeneration upon implantation. Moreover, the spatial control of the electrical field using 
sophisticated devices or conduits could enable simultaneous and local differentiation of 
same stem cell sources into different lineages (SCs and neuronal-like phenotypes) and 
could also impact migration to act synergistically for enhanced PN regeneration. Moreover, 
nerve growth conduits manufactured with sufficiently conductive, flexible, biocompatible, and 
microstructured materials for cellular adhesion, growth, differentiation and proliferation still 
need to be developed to perform in vivo nerve regeneration via implantation and 
differentiation of stem cells. Cellular mechanisms behind stem cell differentiation and nerve 
regeneration via electrical stimulation should also be elucidated in more detail along with the 
cellular interactions with the physical cues of conduits, such as microstructural and 
mechanical properties. Such study directions will pave the way for stem cell based therapies 
for peripheral nerve regeneration and facilitate their translation to clinical applications. 
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The use of adult stem cells holds considerable potential for nerve regeneration applications due to 
their ability to differentiate into specific cell lineages. This progress report particularly focuses on the 
recent advances in adult stem cell differentiation strategies including scaffold/conduit materials and 
electrical /chemical stimulation methods for peripheral nerve regeneration.  
 
